Worth H - Search Results

1

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.

Demoly P, Louis R, Søes-Petersen U, Naya I, Carlsheimer A, Worth H, Almeida J, Sears MR. Demoly P, et al. Among authors: worth h. Respir Med. 2009 Nov;103(11):1623-32. doi: 10.1016/j.rmed.2009.07.018. Epub 2009 Sep 16. Respir Med. 2009. PMID: 19762222 Free article.

2

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.

Worth H, Förster K, Eriksson G, Nihlén U, Peterson S, Magnussen H. Worth H, et al. Respir Med. 2010 Oct;104(10):1450-9. doi: 10.1016/j.rmed.2010.07.006. Epub 2010 Aug 7. Respir Med. 2010. PMID: 20692140 Free article. Clinical Trial.

3

Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD.

Worth H, Chung KF, Felser JM, Hu H, Rueegg P. Worth H, et al. Respir Med. 2011 Apr;105(4):571-9. doi: 10.1016/j.rmed.2010.11.027. Epub 2011 Jan 11. Respir Med. 2011. PMID: 21227674 Free article.

4

GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.

Worth H, Buhl R, Criée CP, Kardos P, Lossi NS, Vogelmeier CF. Worth H, et al. Respir Med. 2017 Oct;131:77-84. doi: 10.1016/j.rmed.2017.08.008. Epub 2017 Aug 9. Respir Med. 2017. PMID: 28947047 Free article.

5

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.

Worth H, Criée CP, Vogelmeier CF, Kardos P, Becker EM, Kostev K, Mokros I, Schneider A. Worth H, et al. Respir Res. 2021 Apr 16;22(1):108. doi: 10.1186/s12931-021-01701-3. Respir Res. 2021. PMID: 33863317 Free PMC article.

6

Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial.

Worth H, Schacher C, Dethlefsen U. Worth H, et al. Respir Res. 2009 Jul 22;10(1):69. doi: 10.1186/1465-9921-10-69. Respir Res. 2009. PMID: 19624838 Free PMC article. Clinical Trial.

7

Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.

Miravitlles M, Worth H, Soler Cataluña JJ, Price D, De Benedetto F, Roche N, Godtfredsen NS, van der Molen T, Löfdahl CG, Padullés L, Ribera A. Miravitlles M, et al. Among authors: worth h. Respir Res. 2014 Oct 21;15(1):122. doi: 10.1186/s12931-014-0122-1. Respir Res. 2014. PMID: 25331383 Free PMC article.

8

Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.

Donohue JF, Fogarty C, Lötvall J, Mahler DA, Worth H, Yorgancioglu A, Iqbal A, Swales J, Owen R, Higgins M, Kramer B; INHANCE Study Investigators. Donohue JF, et al. Among authors: worth h. Am J Respir Crit Care Med. 2010 Jul 15;182(2):155-62. doi: 10.1164/rccm.200910-1500OC. Epub 2010 May 12. Am J Respir Crit Care Med. 2010. PMID: 20463178 Clinical Trial.

9

[Solid combination of budesonide and formoterol in the treatment of bronchial asthma].

Gillissen A, Buhl R, Magnussen H, Menz G, Rabe K, Vogelmeier C, Worth H. Gillissen A, et al. Among authors: worth h. Pneumologie. 2001 Mar;55(3):159-62. doi: 10.1055/s-2001-12436. Pneumologie. 2001. PMID: 11293852 Review. German. No abstract available.

10

Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD.

Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL, Roche N, Similowski T, Watz H, Worth H, Miravitlles M. Rossi A, et al. Among authors: worth h. Respir Med. 2015 Jul;109(7):785-802. doi: 10.1016/j.rmed.2015.03.010. Epub 2015 Apr 3. Respir Med. 2015. PMID: 25892293 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page